Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
9.15
-0.10 (-1.08%)
At close: Nov 4, 2025, 4:00 PM EST
9.00
-0.15 (-1.64%)
After-hours: Nov 4, 2025, 4:23 PM EST

Elicio Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Nov '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
1495580---
Upgrade
Market Cap Growth
191.01%-31.39%----
Upgrade
Enterprise Value
1425572---
Upgrade
Last Close Price
9.155.108.34---
Upgrade
PB Ratio
81.14-4.867.04---
Upgrade
P/TBV Ratio
81.44-7.04---
Upgrade
Debt / Equity Ratio
8.13-2.300.610.84-2.880.03
Upgrade
Quick Ratio
2.231.531.320.900.494.53
Upgrade
Current Ratio
2.281.801.681.560.554.67
Upgrade
Return on Equity (ROE)
-60013.19%-170157.38%-346.95%-1170.93%-430.76%-136.60%
Upgrade
Return on Assets (ROA)
-123.26%-101.64%-89.70%-79.16%-92.36%-68.96%
Upgrade
Return on Capital (ROIC)
-259.55%-170.31%-128.82%-123.12%-130.00%-80.83%
Upgrade
Earnings Yield
-36.56%-94.42%-43.93%---
Upgrade
FCF Yield
-23.52%-67.60%-40.89%---
Upgrade
Buyback Yield / Dilution
-45.98%-141.35%-1500.08%97.93%-42.39%-172.21%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q